SEC CIK 1064641 · Series S000006412 · Portfolio as of 2026-06-30
| Security | Value | Weight |
|---|---|---|
| Eli Lilly & Co · LLY | $6.70B | 16.52% |
| Johnson & Johnson · JNJ | $4.32B | 10.64% |
| AbbVie Inc · ABBV | $3.14B | 7.74% |
| UnitedHealth Group Inc · UNH | $2.67B | 6.57% |
| Merck & Co Inc · MRK | $2.24B | 5.53% |
| Amgen Inc · AMGN | $1.38B | 3.40% |
| Thermo Fisher Scientific Inc · TMO | $1.32B | 3.24% |
| Abbott Laboratories · ABT | $1.12B | 2.75% |
| Gilead Sciences Inc · GILD | $1.11B | 2.73% |
| Intuitive Surgical Inc · ISRG | $995.0M | 2.45% |
From N-PORT Part B, units verified by net-asset reconciliation.
curl "https://api.fundlens.io/v1/funds/XLV/holdings" \
-H "x-api-key: your_api_key"Full holdings, every historical snapshot, point-in-time queries, monthly returns and flows — free tier available, no card required.
Source: SEC EDGAR Form N-PORT. Data is quarterly with a regulatory filing lag; this page shows the most recent public filing. Not investment advice.